Mylan Dodges Contract Breach Claim In Takeda IP Fight
By Adam Lidgett · September 27, 2023, 7:13 PM EDT
A Delaware federal judge on Wednesday agreed to hand Mylan a win on a breach of contract claim from Takeda Pharmaceuticals USA Inc. over its gout drug Colcrys, agreeing with Mylan's...
To view the full article, register now.